Pediatric Crohn’s disease: Adalimumab plus methotrexate offers strong benefitApril 14, 2023IBD & Intestinal Disorders
Clinical Practice Update: Alpha-gal syndrome often causes GI issues without anaphylaxis, skin changesApril 6, 2023IBD & Intestinal DisordersMixed Topics
Vedolizumab appears effective for inducing remission in chronic pouchitisApril 5, 2023IBD & Intestinal Disorders
FDA approves new formulation of Hyrimoz adalimumab biosimilarMarch 27, 2023IBD & Intestinal Disorders
Upadacitinib shows positive endoscopic outcomes in Crohn’s disease at 1 yearMarch 16, 2023IBD & Intestinal Disorders
AI helps predict ulcerative colitis remission/activity, flare-upsMarch 15, 2023IBD & Intestinal Disorders
COVID raises risk for long-term GI complicationsMarch 14, 2023Upper GI TractIBD & Intestinal DisordersPancreas and Biliary Tract
Crohn’s disease remission rates ‘remarkably higher’ with vedolizumabMarch 9, 2023IBD & Intestinal Disorders
DNA panels could predict endoscopic response to biologics in Crohn’s diseaseMarch 7, 2023IBD & Intestinal Disorders
